SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

EVANS BARRETT

(Last)

(First)

(Middle)

(Street)

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/09/2007

3. Issuer Name and Ticker or Trading Symbol
GENESIS BIOVENTURES INC [ GBIW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	115,000	I	see fotenote (1)⁽¹⁾
Common Stock	500,000	I	see footnote (1)⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series C Convertible Preferred Stock	08/08/2007	⁽²⁾	Common Stock	100	⁽³⁾	I	see footnote (1)⁽¹⁾
Convertible Debenture	05/09/2007	⁽⁴⁾	Common Stock	$250,000	⁽⁵⁾	I	see footnote (1)⁽¹⁾

Explanation of Responses:

1. Barrett Evans is the managing member of eFund Capital Partners, LLC and a managing member of eFund Capital Management, LLC. eFund Capital Partners, LLC acts as general partner to eFund Small Cap Fund, LP. eFund Small Cap Fund, LP purchased 115,000 shares of common stock in the open market. eFund Capital Management, received 500,000 shares of common stock as an inducement to enter into a $250,000 debenture agreement with the Company on May 9, 2007. eFund Capital Management, LLC also received 100 shares of Series C Convertible Preferred Stock on August 8, 2007 pursuant to a consulting agreement with the Company.

2. There is no expiration date for the conversion of Series C Convertible Preferred Stock.

3. Each shares of Series C Convertible Preferred Stock shall be converted into a number of shares of common stock that equals one-tenth of a percent (0.1%) of the Company's outstanding common stock immediately following the conversion date.

4. There is no expiration on the convertible debenture and it may be converted at any time.

5. The convertible debenture is convertible into the Company's common stock at a conversion price of the lesser of (i) 75% of the lowest closing bid price of the common stock for the fifteen trading day period prior to conversion; or (ii) at eight cents ($0.08) per share.

	Barrett Evans	11/09/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.